Inventor · disambiguated record
Craig J. Thomas
Also filed as: THOMAS CRAIG · THOMAS CRAIG J · THOMAS CRAIG JOSEPH
23 granted patents·16 pending applications·69 citations·filing 2007–2023
93Inventor score
Top patents by PatentIndex Score
39 records- 0195US9708267B2Activators of human pyruvate kinaseUS HEALTH·Filed 2015·Granted Jul 18, 2017·16 cites·20 claims
- 0292US11542261B2Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitorsCHILDRENS HOSPITAL MED CT·Filed 2020·Granted Jan 3, 2023·9 cites·19 claims
- 0392US8841305B2Activators of the human pyruvate kinase M2 receptorTHOMAS CRAIG J·Filed 2009·Granted Sep 23, 2014·24 cites·26 claims
- 0490US11613514B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2021·Granted Mar 28, 2023·2 cites·15 claims
- 0589US10919842B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2017·Granted Feb 16, 2021·4 cites·4 claims
- 0689US9303044B27-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disordersUNIV ROCKEFELLER·Filed 2013·Granted Apr 5, 2016·8 cites·20 claims
- 0779US9532989B2Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidinesUS HEALTH·Filed 2015·Granted Jan 3, 2017·2 cites·12 claims
- 0878US9066948B2Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidinesCOLLER BARRY S·Filed 2011·Granted Jun 30, 2015·2 cites·6 claims
- 0975US12473251B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2023·Granted Nov 18, 2025·0 cites·3 claims
- 1071US11897875B2Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disordersUNIV MARYLAND·Filed 2022·Granted Feb 13, 2024·0 cites·10 claims
- 1167US9365612B2Caspase inhibitorsTHOMAS CRAIG·Filed 2011·Granted Jun 14, 2016·2 cites·16 claims
- 1263US9290512B2Activators of human pyruvate kinaseUS HEALTH·Filed 2014·Granted Mar 22, 2016·0 cites·13 claims
- 1362US2022235042A1Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 InhibitorsCHILDRENS HOSPITAL MED CT·Filed 2022·Application pending·0 cites
- 1461US11186539B2Process for synthesis and purification of (2R,6R)-hydroxynorketamineUS HEALTH·Filed 2019·Granted Nov 30, 2021·0 cites·19 claims
- 1560US9296729B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsUS HEALTH·Filed 2014·Granted Mar 29, 2016·0 cites·38 claims
- 1659US11459320B2Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disordersUNIV MARYLAND·Filed 2018·Granted Oct 4, 2022·0 cites·6 claims
- 1758US9707230B2Activators of human pyruvate kinaseUS HEALTH·Filed 2016·Granted Jul 18, 2017·0 cites·21 claims
- 1858US9187457B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsUS HEALTH·Filed 2013·Granted Nov 17, 2015·0 cites·21 claims
- 1958US8937067B2Activators of human pyruvate kinaseTHOMAS CRAIG J·Filed 2012·Granted Jan 20, 2015·0 cites·12 claims
- 2058US2025361230A1LATS Inhibitors and Uses ThereofTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEATH AND HUMAN SERVICES·Filed 2023·Application pending·0 cites
- 2158US2025368648A1Multi-cyclic irak and flt3 inhibiting compounds and uses thereofCHILDRENS HOSPITAL MED CT·Filed 2023·Application pending·0 cites
- 2257US8741259B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsGERSHENGORN MARVIN C·Filed 2008·Granted Jun 3, 2014·0 cites·28 claims
- 2356US9458141B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsUS HEALTH·Filed 2015·Granted Oct 4, 2016·0 cites·7 claims
- 2453US2008182805A1O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-Acetyl moietyGOV OF THE U S A AS REPRESENTE·Filed 2007·Application pending·0 cites
- 2553US2023331655A1Hydroxynorketamine compounds and methods of use thereofUNIV MARYLAND·Filed 2021·Application pending·0 cites
- 2652US2022213094A1Substituted Imidazo[l,2-a]-pyridines as IRAK 1/4 and FLT3 InhibitorsCHILDRENS HOSPITAL MED CT·Filed 2022·Application pending·0 cites
- 2752US2024294530A1Multi-cyclic irak and flt3 inhibiting compounds and uses thereofCHILDRENS HOSPITAL MED CT·Filed 2021·Application pending·0 cites
- 2851US2025154144A1Multi-cyclic irak and flt3 inhibiting compounds and uses thereofCHILDRENS HOSPITAL MED CT·Filed 2022·Application pending·0 cites
- 2950US2011207784A1Oxadiazole-2-oxides as antischistosomal agentsUS HEALTH·Filed 2009·Application pending·0 cites
- 3050US2021246099A1Process for synthesis and purification of (2r,6r)-hydroxynorketamineTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 3146US2009203716A1Pyrimidine low molecular weight ligands for modulating hormone receptorsUS HEALTH·Filed 2008·Application pending·0 cites
- 3245US2023303563A1Multi-cyclic irak and flt3 inhibiting compounds and uses thereofCHILDRENS HOSPITAL MED CT·Filed 2021·Application pending·0 cites
- 3344US2011112079A1Phosphodiesterase inhibitorsTHOMAS CRAIG J·Filed 2009·Application pending·0 cites
- 3441US2019083420A1Methods of using (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, fatigue, suicidal ideation, and post traumatic stress disordersUS HEALTH·Filed 2017·Application pending·0 cites
- 3540US2013109672A1Activators of human pyruvate kinaseBOXER MATTHEW B·Filed 2011·Application pending·0 cites
- 3636US11254667B2Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitorsCHILDRENS HOSPITAL MED CT·Filed 2017·Granted Feb 22, 2022·0 cites·38 claims
- 3735US8993768B2Tropolone compounds for treating or preventing retroviral infectionBEUTLER JOHN A·Filed 2012·Granted Mar 31, 2015·0 cites·26 claims
- 3833US9206154B2Inverse agonists and neutral antagonists for the TSH receptorGERSHENGORN MARVIN·Filed 2011·Granted Dec 8, 2015·0 cites·61 claims
- 3926US2017166558A1O-glcnac transferase (ogt) inhibitors and uses thereofHARVARD COLLEGE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Craig J. Thomas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →